.

Deeper Knowledge, Faster

  • Find suppliers and generic API sources
  • Uncover prior art in expired and abandoned patents
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Fuji
US Department of Justice
Teva
Deloitte
Federal Trade Commission
Queensland Health
Daiichi Sankyo
Covington
Dow
Boehringer Ingelheim

Generated: June 24, 2017

DrugPatentWatch Database Preview

PROBALAN Drug Profile

« Back to Dashboard

What is the patent landscape for Probalan, and when can generic versions of Probalan launch?

Probalan is a drug marketed by Lannett and is included in one NDA.

The generic ingredient in PROBALAN is probenecid. There are ten drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the probenecid profile page.

Summary for Tradename: PROBALAN

Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list4
Bulk Api Vendors: see list66
Clinical Trials: see list1
Patent Applications: see list5,035
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:PROBALAN at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lannett
PROBALAN
probenecid
TABLET;ORAL080966-001Approved Prior to Jan 1, 1982ABRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Fuji
Argus Health
McKesson
Merck
Express Scripts
Cipla
Teva
Covington
Citi
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot